DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Applicant’s election without traverse of Group II (claims 8-9), in the reply filed on 08/26/26 is acknowledged.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claim 8 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Independent claim 8 is indefinite in regard to the exact meaning of the phrase: “coexists in an oxidation inhibition object.” [Emphasis added]. Is the “oxidation inhibition object” referring to an object (e.g. food oils, unsaturated fatty acids and other compounds containing reactive double bounds) that can be subjected to unwanted oxidation reactions? If so, the above wording of the phrase is very unclear and the Examiner suggests the phrase should be amended to read something like: --coexists in combination with an object that is subjected to unwanted oxidation reactions--.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Examination Note:
It seems, according to Applicant’s specification, that applicant’s invention is drawn to the concept of the incorporation of polyalkylene imine (e.g. polyethyleneimine) antioxidants into other types of antioxidants (e.g. vitamin E) to improve the antioxidant effectiveness of said other types of antioxidants, especially when they are used to inhibit oxidation of oxidation susceptible objects (e.g. food oils, unsaturated fatty acids and other compounds containing reactive double bounds).
Claim(s) 8-9 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Nguyen et al. U.S. Patent Application Publication No.: 2008/0095728 A1.
Nguyen et al. discloses an aqueous composition containing: (a) at least one polyamine compound having at least three amino groups; (b) at least one nonionic surfactant; (c) at least one phosphate ester chosen from alkoxylated alkyl phosphate esters and alkyl phosphate esters; and (d) at least one water-insoluble material, and wherein the composition is both homogeneous, and clear to substantially clear in appearance, see abstract.
Applicant’s claims are deemed to be anticipated over the process of making Mixtures A, C, D and F in Example 1, because all said mixtures comprise: D.I water, polyethyleneimine (PEI), Procetyl AWS, Crodafos SG, and Olive oil.
Please note that olive oil, which is a mixtures of various unsaturated fatty acids, reads on Applicant’s “oxidation inhibiting substance” of claims 8-9, because it contains alpha-tocopherol (vitamin E), an extremely well known anti-oxidant. Also note that olive oil additionally reads on Applicant’s “oxidation inhibition object” of claim 8, because it is a mixtures of various unsaturated fatty acids, which even in the presence of the vitamin E antioxidant, can still undergo unwanted oxidation reactions resulting in the production of peroxide radicals and aldehydes.
Claim(s) 8-9 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by CN 104849959 A.
CN 104849959 A discloses a photosensitive adhesive comprises 60-80 pts. wt. 30% polyvinyl alcohol, 15-20 pts. wt. gelatin, 18-30 pts. wt. diazo-diphenylamine paraformaldehyde condensate, 4-10 pts. wt. polyisocyanate block material, 10-15 pts. wt. silicone-modified polyurethane resin, 15-20 pts. wt. trimethylolethane, 3-6 pts. wt. styrylpyridine dimethyl sulfate salt, 2-8 pts. wt. hydroquinone, 10-12 pts. wt. hardener, 1-4 pts. wt. polyethyleneimine, 7-15 pts. wt. boron trifluoride ethylamine salt, 3-6 pts. wt. benzyldimethylamine, 8-10 pts. wt. aluminum chloride hexahydrate, 50-100 pts. wt. solvent, 0.2-0.3 pt. wt. reactive brilliant blue, 2-5 pts. wt. silicone defoamer and 0.05-1 pt. wt. vitamin E.
Applicant’s claims are deemed to be anticipated over the process of adding the said various components together to make said photosensitive adhesive composition. Please note that the hydroquinone and vitamin E components, individually read on Applicant’s “oxidation inhibiting substance” of claims 8-9 because they are extremely well known antioxidants. Also note that the polyisocyanate block material and the reactive brilliant blue components, individually read on Applicant’s “oxidation inhibition object” of claim 8 because they both have reactive double bonds that can be subjected to either premature oxidation reactions or unwanted oxidation reactions.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSEPH DAVID ANTHONY whose telephone number is (571)272-1117. The examiner can normally be reached M-F: 10:00AM-6:30PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie (Lanee) Reuther can be reached at 571-270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JOSEPH D ANTHONY/Primary Examiner, Art Unit 1764